Aviir pumps in $7.8M for heart diagnostics
Stealthy biotech firm Aviir just raised a $7.8 million bridge round of financing to last it through the rest of 2009, according to VentureWire. Based in Palo Alto, Calif., the company hasn’t released much information about its actual products — only that its methods may eventually be used to detect early warning signs of heart disease, heart attacks or strokes on the molecular level.
Born out of research conducted in Stanford University labs, the technology will be ready to go to market sometime in the next two years, according to the company’s web site. To make this a reality, Aviir will look to raise more money before the year is out.
Investors in the recent round are Aberdare Ventures, Bay City Capital and New Leaf Venture Partners. It last raised funds in March amounting to $1.5 million.
Next Story: The U.S. Congress: The new stars of YouTube?
Previous Story: Deca.tv snaps up $10M for online production studio
About the Author, Camille Ricketts
Camille is the lead writer for GreenBeat. She came to VentureBeat from Google where she worked on its traditional platforms team, particularly in TV. Before that, she was a reporter for the Wall Street Journal in New York and London. Follow her on Twitter at @camillericketts, and follow VentureBeat on Twitter at @venturebeat.